drugset / Trial / NCT01961505
Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
Rheumatoid Arthritis (RA) is an autoimmune disease that results in a chronic inflammatory disorder that may affect many synovial joints, and may cause serious disability. It has been confirmed that Tripterygium wilfordii Hook F has effects of anti-inflammatory, immunosuppressive and cartilage protection. This is a prospective randomized controlled study to evaluated the efficacy and safety of external application with compound Tripterygium wilfordii Hook F in treating of patients with rheumatoid arthritis (RA).
Timeline
- Start
- 2011-10
- Primary completion
- 2015-09
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | compound tripterygium | Unknown | 3 ml | Topical |
| Subject | compound tripterygium | Unknown | 5 ml | Topical |
| Subject | compound tripterygium | Unknown | 10 ml | Topical |